Form D · Biotechnology
OSTEOGENIX INC
Palo Alto, CA · CIK 0001391781
Offering snapshot reported Jun 16, 2009 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 1, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 16, 2009 | Initial | $600,000 | No comparison | 1 | SEC filing |
| Feb 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-100564
Source: Form D, filed Jun 16, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Olga Karobkoff | Executive |
| Thomas Kiley | Director |
| Gregory Mundy | Director, Executive |
| Joseph Rockovich | Executive |
| Tadmor Shalon | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
532 Emerson St
Palo Alto, CA, 94301
Palo Alto, CA, 94301